BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19018760)

  • 1. Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population.
    Takahashi H; Takayama T; Yoneda K; Endo H; Iida H; Sugiyama M; Fujita K; Yoneda M; Inamori M; Abe Y; Saito S; Wada K; Nakagama H; Nakajima A
    Cancer Sci; 2009 Jan; 100(1):29-32. PubMed ID: 19018760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the plasma level of insulin-like growth factor-1 with the number of aberrant crypt foci in male individuals.
    Takahashi H; Takayama T; Hosono K; Yoneda K; Endo H; Nozaki Y; Fujita K; Yoneda M; Inamori M; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakagama H; Nakajima A
    Mol Med Rep; 2009; 2(3):339-43. PubMed ID: 21475834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.
    Otake S; Takeda H; Suzuki Y; Fukui T; Watanabe S; Ishihama K; Saito T; Togashi H; Nakamura T; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2005 May; 11(10):3642-6. PubMed ID: 15897559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frequency of serrated aberrant crypt foci among smokers.
    Anderson JC; Pleau DC; Rajan TV; Protiva P; Swede H; Brenner B; Heinen CD; Lambrecht RW; Rosenberg DW
    Am J Gastroenterol; 2010 Jul; 105(7):1648-54. PubMed ID: 20234347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance.
    Koh SJ; Hyun YJ; Choi SY; Chae JS; Kim JY; Park S; Ahn CM; Jang Y; Lee JH
    Clin Chim Acta; 2008 Mar; 389(1-2):45-50. PubMed ID: 18082632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral obesity and hypoadiponectinemia are significant determinants of hepatic dysfunction: An epidemiologic study of 3827 Japanese subjects.
    Kamada Y; Nakamura T; Funahashi T; Ryo M; Nishizawa H; Okauchi Y; Fukushima J; Yoshida Y; Kiso S; Shimomura I; Hayashi N
    J Clin Gastroenterol; 2009; 43(10):995-1000. PubMed ID: 19407661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon epithelial proliferation and carcinogenesis in diet-induced obesity.
    Takahashi H; Hosono K; Endo H; Nakajima A
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():41-7. PubMed ID: 24251703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
    Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
    Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
    Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
    Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.
    Engl J; Sturm W; Sandhofer A; Kaser S; Tschoner A; Tatarczyk T; Weiss H; Tilg H; Patsch JR; Ebenbichler CF
    Eur J Clin Invest; 2008 Apr; 38(4):238-44. PubMed ID: 18312420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
    Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
    Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci.
    Lindzon GM; Medline A; Sohn KJ; Depeint F; Croxford R; Kim YI
    Carcinogenesis; 2009 Sep; 30(9):1536-43. PubMed ID: 19541855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
    Gupta AK; Schoen RE
    Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.
    Stevens RG; Swede H; Heinen CD; Jablonski M; Grupka M; Ross B; Parente M; Tirnauer JS; Giardina C; Rajan TV; Rosenberg DW; Levine J
    Cancer Lett; 2007 Apr; 248(2):262-8. PubMed ID: 16950561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.
    Seike K; Koda K; Oda K; Kosugi C; Shimizu K; Nishimura M; Shioiri M; Takano S; Ishikura H; Miyazaki M
    Am J Gastroenterol; 2006 Jun; 101(6):1362-9. PubMed ID: 16771962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative relation of general, central, and visceral adiposity measures for coronary artery calcium in subjects without previous coronary events.
    Ho JS; Cannaday JJ; Barlow CE; Willis B; Haskell WL; FitzGerald SJ
    Am J Cardiol; 2009 Oct; 104(7):943-6. PubMed ID: 19766761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
    Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
    Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat volume and the prevalence of colorectal adenoma.
    Yamaji T; Iwasaki M; Sasazuki S; Kurahashi N; Mutoh M; Yamamoto S; Suzuki M; Moriyama N; Wakabayashi K; Tsugane S
    Am J Epidemiol; 2009 Dec; 170(12):1502-11. PubMed ID: 19923108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.